Summary
- Splice variants
- Transcript comparison
- Gene alleles
Sequence
- Secondary Structure
Comparative Genomics
- Genomic alignments
- Gene tree
- Gene gain/loss tree
- Orthologues
- Paralogues
Ontologies
- GO: Anatomical entity
Phenotypes
Genetic Variation
Gene expression
Pathway
Molecular interactions
External references
Supporting evidence
ID History
- Gene history

Configure this page

Share this page

Bookmark this page

.

Gene: shld2 ENSDARG00000038686

.

Description

shieldin complex subunit 2 [Source:NCBI gene (formerly Entrezgene);Acc:100149820]

Location

Chromosome 13: 22,698,215-22,715,102 forward strand.

GRCz11:CM002897.2

About this gene

This gene has 3 transcripts (splice variants) and 193 orthologues.

Transcripts

Show transcript tableHide transcript table

Transcript ID	Name	bp	Protein	Translation ID	Biotype	UniProt Match	Flags
ENSDART00000137467.3	shld2-203	2820	784aa	ENSDARP00000117245.1	Gene/transcipt that contains an open reading frame (ORF).Protein coding	B8A4B1	A single transcript chosen for a gene which is the most conserved, most highly expressed, has the longest coding sequence and is represented in other key resources, such as NCBI and UniProt. This is defined in detail on http://www.ensembl.org/info/genome/genebuild/canonical.htmlEnsembl Canonical, APPRIS P1: Transcript(s) expected to code for the main functional isoform based solely on the core modules in the APPRIS. APPRIS is a system to annotate alternatively spliced transcripts based on a range of computational methods to identify the most functionally important transcript(s) of a gene. APPRIS P1,
ENSDART00000132847.2	shld2-202	841	218aa	ENSDARP00000112563.1	Gene/transcipt that contains an open reading frame (ORF).Protein coding	-	5' truncation in transcript evidence prevents annotation of the start of the CDS.CDS 5' incomplete,
ENSDART00000131696.2	shld2-201	3097	No protein	-	An alternatively spliced transcript believed to contain intronic sequence relative to other, coding, transcripts of the same gene.Retained intron	-	-

.

Summary

.

.